FocusAutism

Tweaking the Social Network

Science Translational Medicine  25 Apr 2012:
Vol. 4, Issue 131, pp. 131fs9
DOI: 10.1126/scitranslmed.3004017

You are currently viewing the Array.

View Full Text

Log in


Abstract

Paving the way for clinical trials, a new study shows that a glutamate receptor antagonist reduces repetitive behavior and social deficits in a mouse model of autism spectrum disorder.

View Full Text